AKRO Historical Earnings image   This AKRO historical earnings page last updated 11/22/2024
AKRO Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202411/8/2024NA
Q2 20248/9/2024NA
Q1 20245/10/2024NA
Q4 20232/29/2024NA
Q3 202311/13/2023NA
Q2 20238/11/2023NA
Q1 20235/15/2023NA
Q4 20223/17/2023NA
Q3 202211/4/2022NA
Q2 20228/4/2022NA
Q1 20225/6/2022NA
Q4 20212/25/2022NA
Q3 202111/12/2021NA
Q2 20218/13/2021NA
Q1 20215/13/2021NA
Q4 20203/16/2021NA
Q3 202011/12/2020NA
Q2 20208/12/2020NA
Q1 20205/13/2020NA
Q4 20193/16/2020NA
Q3 201911/12/2019NA
Q2 20198/12/2019NA
AKRO Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202411/8/2024-1.050
Q2 20248/9/2024-0.810
Q1 20245/10/2024-0.900
Q4 20232/29/2024-0.990
Q3 202311/13/2023-0.710
Q2 20238/11/2023-0.600
Q1 20235/15/2023-0.550
Q4 20223/17/2023-0.490
Q3 202211/4/2022-0.920
Q2 20228/4/2022-0.770
Q1 20225/6/2022-0.740
Q4 20212/25/2022-0.930
Q3 202111/12/2021-0.700
Q2 20218/13/2021-0.830
Q1 20215/13/2021-0.430
Q4 20203/16/2021-0.860
Q3 202011/12/2020-0.630
Q2 20208/12/2020-0.570
Q1 20205/13/2020-0.420
Q4 20193/16/2020-0.55
Q3 201911/12/2019-0.560
Q2 20198/12/2019-2.210
Quotes delayed 20 minutes

Email EnvelopeFree AKRO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Akero Therapeutics (AKRO) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

AKUS Historical Earnings
AKYA Historical Earnings
ALBO Historical Earnings
ALDX Historical Earnings
ALEC Historical Earnings
ALGN Historical Earnings
ALGS Historical Earnings
ALHC Historical Earnings
ALIM Historical Earnings
ALKS Historical Earnings
What was the record high AKRO historical earnings result?
In terms of earnings or revenue, what is the best AKRO historical earnings result that Akero Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest AKRO historical earnings result was set in Q1 2020, when Akero Therapeutics posted results of -0.420/share. The most successful revenue quarter within our data set was Q3 2024 when Akero Therapeutics reported revenue of NA.

What was the lowest Akero Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest AKRO has reported, and when?

✔️Accepted answer: Within our data set, the lowest AKRO historical earnings result was set in Q2 2019, when Akero Therapeutics posted results of -2.210/share. The smallest revenue quarter within our data set was Q3 2024 when Akero Therapeutics reported revenue of NA.

On this page we presented the AKRO historical earnings date information for Akero Therapeutics. Reviewing that AKRO Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2020, when AKRO posted gaap of -0.420/share. Meanwhile the lowest AKRO historical earnings result was in Q2 2019, when AKRO posted gaap of -2.210/share. Moving to Akero Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q3 2024 when AKRO reported NA in revenue, while the smallest revenue quarter was Q3 2024 when AKRO reported NA in revenue.

For self directed investors doing their due diligence on AKRO or any other given stock, their research can benefit from looking into all of the Akero Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Akero Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for AKRO. Thanks for visiting, and the next time you need to research AKRO historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: HUBG shares outstanding history, ZK Stock Predictions, ZIP shares outstanding history.

 

AKRO Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.